Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun;23(6):887-8.
doi: 10.1038/ejhg.2014.164. Epub 2014 Aug 13.

VPS35 and DNAJC13 disease-causing variants in essential tremor

Affiliations

VPS35 and DNAJC13 disease-causing variants in essential tremor

Alex Rajput et al. Eur J Hum Genet. 2015 Jun.

Abstract

Exome-sequencing analyses have identified vacuolar protein sorting 35 homolog (VPS35) and DnaJ (Hsp40) homolog, subfamily C, member 13 (DNAJC13) harboring disease-causing variants for Parkinson disease (PD). Owing to the suggested clinical, pathological and genetic overlap between PD and essential tremor (ET) we assessed the presence of two VPS35 and DNAJC13 disease-causing variants in ET patients. TaqMan probes were used to genotype VPS35 c.1858G>A (p.(D620N)) (rs188286943) and DNAJC13 c.2564A>G (p.(N855S)) (rs387907571) in 571 ET patients of European descent, and microsatellite markers were used to define the disease haplotype in variant carriers. Genotyping of DNAJC13 identified two ET patients harboring the c.2564A>G (p.(N855S)) variant previously identified in PD patients. Both patients appear to share the disease haplotype previously reported. ET patients with the VPS35 c.1858G>A (p.(D620N)) variants were not observed. Although a genetic link between PD and ET has been suggested, DNAJC13 c.2564A>G (p.(N855S)) represents the first disease-causing variant identified in both, and suggests the regulation of clathrin dynamics and endosomal trafficking in the pathophysiology of a subset of ET patients.

PubMed Disclaimer

Conflict of interest statement

AR has received research support from the Regina Curling Classic, Greystone Classic for Parkinson's, Inc., the Dr Ali Rajput Endowment for Parkinson's Disease and Movement Disorders and the International Essential Tremor Foundation, and has participated in clinical trials funded by Teva (TVP-1012/501) and Merck Serono SA-Geneva (EMR 701165-024). Has also received honoraria from Teva and UCB Canada Inc. AHR receives research support from the Saskatchewan Parkinson's Disease Foundation, Curling Classic, and PrintWest Golf Classic, and has received a travel grant from Teva. ZKW is funded by NIH NS072187 and is the Editor in Chief of Parkinsonism and Related Disorders. OAR is a member of the editorial board of PLoS ONE and American Journal of Neurodegenerative Disease and Parkinsonism and Related Disorders, and he is funded by NIH grants NS078086 and NS072187. The remaining authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Vilarino-Guell C, Wider C, Ross OA et al: LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010; 11: 401–408. - PMC - PubMed
    1. Vilarino-Guell C, Wider C, Ross OA et al: VPS35 mutations in Parkinson disease. Am J Hum Genet 2011; 89: 162–167. - PMC - PubMed
    1. Jasinska-Myga B, Wider C: Genetics of essential tremor. Parkinsonism Relat Disord 2012; 18 (Suppl 1): S138–S139. - PubMed
    1. Rajput A, Robinson CA, Rajput AH: Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology 2004; 62: 932–936. - PubMed
    1. Vilarino-Guell C, Rajput A, Milnerwood AJ et al: DNAJC13 mutations in Parkinson disease. Hum Mol Genet 2014; 23: 1794–1801. - PMC - PubMed

Publication types

LinkOut - more resources